Relationship between clinical severity of respiratory syncytial virus infection and subtype.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 1511617)

Published in Arch Dis Child on August 01, 1996

Authors

M C Kneyber1, A H Brandenburg, P H Rothbarth, R de Groot, A Ott, H A van Steensel-Moll

Author Affiliations

1: Department of Paediatrics, Sophia Children's Hospital/University Hospital Rotterdam, Netherlands.

Articles citing this

Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol (2006) 1.55

Human metapneumovirus, Australia, 2001-2004. Emerg Infect Dis (2006) 1.18

Respiratory syncytial virus genotypes and disease severity among children in hospital. Arch Dis Child (1997) 1.08

Local variability in respiratory syncytial virus disease severity. Arch Dis Child (1997) 1.04

Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J (2013) 0.96

Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS One (2013) 0.93

Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production. Am J Pathol (2007) 0.92

Distribution and seasonality of rhinovirus and other respiratory viruses in a cross-section of asthmatic children in Trinidad, West Indies. Ital J Pediatr (2009) 0.88

G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol (2000) 0.86

Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort. J Infect Dis (2015) 0.80

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. PLoS One (2014) 0.78

Viral agents causing lower respiratory tract infections in hospitalized children: evaluation of the Speed-Oligo® RSV assay for the detection of respiratory syncytial virus. Eur J Clin Microbiol Infect Dis (2011) 0.77

Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children. Pediatr Res (2015) 0.75

Clinical Profiles of Respiratory Syncytial Virus Subtypes A and B among Children Hospitalized with Bronchiolitis. Pediatr Infect Dis J (2017) 0.75

A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus. Sci Rep (2017) 0.75

Articles cited by this

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol (1973) 4.47

Clinical findings and severity of acute bronchiolitis. Lancet (1990) 2.43

Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41

Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet (1989) 2.03

Comparison of direct and indirect immunofluorescence staining of clinical specimens for detection of respiratory syncytial virus antigen. J Clin Microbiol (1982) 1.72

Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr (1990) 1.60

American Academy of Pediatrics Committee on Infectious Diseases: Ribavirin therapy of respiratory syncytial virus. Pediatrics (1987) 1.27

Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila) (1993) 1.21

Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr (1992) 1.20

The respiratory syncitial virus and its role in acute bronchiolitis. Eur J Pediatr (1992) 1.19

Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis J (1993) 1.00

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children. Rev Soc Bras Med Trop (1994) 0.90

Articles by these authors

A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04

Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80

The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology (1998) 3.13

Time scale dependent viscoelastic and contractile regimes in fibroblasts probed by microplate manipulation. J Cell Sci (1997) 2.73

Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67

[Chickenpox: sufficient reasons for the introduction of vaccination]. Ned Tijdschr Geneeskd (2006) 2.61

Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol (1995) 2.55

Prospective application of reverse transcriptase polymerase chain reaction for diagnosing influenza infections in respiratory samples from a children's hospital. J Clin Microbiol (1993) 2.54

NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41

Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13

No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine (2004) 2.13

Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03

Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol (1996) 2.00

Influenza types and patient population. Lancet (1995) 1.94

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis (1999) 1.87

Incidence of dementia: does gender make a difference? Neurobiol Aging (2001) 1.81

Risk factors for vascular disease and dementia. Haemostasis (1999) 1.77

Childhood leukemia and parental occupation. A register-based case-control study. Am J Epidemiol (1985) 1.75

Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol (2007) 1.73

Measurement of the elasticity of the actin tail of Listeria monocytogenes. Eur Biophys J (2000) 1.72

Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69

Origin of two different classes of defective HSV-1 Angelotti DNA. Nucleic Acids Res (1979) 1.62

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA (1997) 1.61

Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol (1986) 1.60

Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis (2003) 1.59

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis (1997) 1.51

Pathophysiology of meningococcal sepsis in children. Eur J Pediatr (1998) 1.46

Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat (2008) 1.45

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology (1995) 1.45

Trapping and wiggling: elastohydrodynamics of driven microfilaments. Biophys J (1998) 1.44

Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study. Neurology (1999) 1.42

Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol (1998) 1.40

[Osteomyelitis as a complication following BCG vaccination]. Ned Tijdschr Geneeskd (1995) 1.39

Ratio of marked and excised sentinel lymph nodes and scintigraphic appearance time in melanoma patients with negative sentinel lymph node. Eur J Surg Oncol (2010) 1.39

Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care (1997) 1.39

Ichthyosis, exocrine pancreatic insufficiency, impaired neutrophil chemotaxis, growth retardation, and metaphyseal dysplasia (Shwachman syndrome). Report of a case with extensive skin lesions (clinical, histological, and ultrastructural findings) Arch Dermatol (1991) 1.38

Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr (2001) 1.31

Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. Am J Epidemiol (1999) 1.31

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31

Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol (1985) 1.31

Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women. J Clin Microbiol (2005) 1.31

Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors. J Clin Microbiol (1998) 1.29

Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol (2001) 1.29

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet (1999) 1.28

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun (2000) 1.28

Filament assembly from profilin-actin. J Biol Chem (1999) 1.27

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol (1997) 1.24

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord (2001) 1.23

Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun (2002) 1.21

Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20

Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues. Biomed Tech (Berl) (1993) 1.19

The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun (2004) 1.17

Synthesis and packaging of herpes simplex virus DNA in the course of virus passages at high multiplicity. Intervirology (1978) 1.16

A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur J Pediatr (1996) 1.16

Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones. J Clin Microbiol (1999) 1.15

Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr (1998) 1.15

Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes. J Med Virol (1994) 1.15

Age-dependent pharmacokinetics of lamivudine in HIV-infected children. Clin Pharmacol Ther (2007) 1.10

The role of nitric oxide in bacterial meningitis in children. J Infect Dis (1996) 1.10

[Epidemiological characteristics of reported HIV-1 infection in children in the Netherlands, 1998-2000: vertical transmission via parents from countries with a generalised epidemic]. Ned Tijdschr Geneeskd (2002) 1.08

The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV). Virus Res (1987) 1.07

Reviewing Omenn syndrome. Eur J Pediatr (2001) 1.07

The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis (1996) 1.06

Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J Infect Dis (2001) 1.06

[Reduction of vertical transmission by means of perinatal prophylaxis in the case of children exposed to HIV-1 and born in the Netherlands during the period 1995-1999]. Ned Tijdschr Geneeskd (2002) 1.06

Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res (2000) 1.05

The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study. Neurology (1999) 1.05

Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology (2006) 1.05

Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G. J Immunol Methods (1996) 1.04

Risk factors for childhood acute non-lymphocytic leukemia: an association with maternal alcohol consumption during pregnancy? Cancer Epidemiol Biomarkers Prev (1994) 1.04

Critical centrifugal forces induce adhesion rupture or structural reorganization in cultured cells. Cell Motil Cytoskeleton (1996) 1.04

Local variability in respiratory syncytial virus disease severity. Arch Dis Child (1997) 1.04

Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis (1995) 1.03

Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr (2000) 1.03

Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis (1997) 1.03

Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res (1994) 1.03

Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun (1997) 1.03

Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol (2000) 1.03

Rearrangement of cortex proteins constitutes an osmoprotective mechanism in Dictyostelium. EMBO J (1999) 1.02

Retinal vasculitis occurring with common variable immunodeficiency syndrome. Am J Ophthalmol (2000) 1.02

Acting on actin: the electric motility assay. Eur Biophys J (1998) 1.01

Flexibility of myosin attachment to surfaces influences F-actin motion. Biophys J (1995) 1.00

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine. Vaccine (2001) 1.00

An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes. Histochemistry (1989) 1.00

Time space distribution of childhood leukaemia in the Netherlands. J Epidemiol Community Health (1983) 0.99

Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. J Neural Transm Suppl (1998) 0.99

Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Δ117 mutation in human stools. J Microbiol Methods (2010) 0.98

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine. Infect Immun (2003) 0.98

Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet (2001) 0.98

Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance. Pediatrics (1995) 0.97